Dupixent biosimilar approved us 2026?

I don’t have real-time data access. As of my latest update, there hasn’t been an FDA-approved dupilumab (Dupixent) biosimilar in the United States by 2026. Several companies have been developing dupilumab biosimilars, and some have had approvals or launches outside the US, but US approval status can change.

If you’d like, I can help you look up the current status (FDA Drug@FDA entries, press releases from Regeneron/Sanofi, or company announcements) and summarize the latest developments. Do you want me to check now?